首页 > 最新文献

Obesity and Metabolism最新文献

英文 中文
Heart rate recovery does not predict endothelial function in obese women. 心率恢复不能预测肥胖妇女的内皮功能。
Q3 Medicine Pub Date : 2007-09-01
Damon L Swift, Brian A Irving, David W Brock, Christopher K Davis, Eugene J Barrett, Glenn A Gaesser, Arthur Weltman

The purpose of the present study was to examine the relationship between heart rate recovery (HR(REC)) and endothelial function in obese women with the metabolic syndrome. The metabolic syndrome has been associated with increased cardiometabolic risk including endothelial dysfunction. However, measurement of endothelial function via flow-mediated dilation (FMD) requires expensive equipment and qualified medical personnel, and therefore may be impractical in some healthcare settings. Heart rate recovery (HR(REC)) has predictive utility with respect to endothelial function in individuals with suspected coronary artery disease and individuals with the metabolic syndrome also have elevated risk for developing coronary artery disease. Thirty-one obese, sedentary women (age: 47.7±11.2 yr, mean±SD) who met the International Diabetes Federation criteria for the metabolic syndrome underwent a brachial artery ultrasound to determine FMD and nitroglycerine-mediated dilation (NTG). HR(REC) was assessed during 5 min of active recovery following a standardized VO(2 Peak) treadmill protocol. Results revealed that the %FMD was not correlated to HR(REC) when examined across all participants (r= 0.067, p=0.72). However, this relationship was significant in participants with impaired FMD (n=16, %FMD<6%) (r=0.71, p=0.002). Although HR(REC) may be a significant correlate of FMD in women with the metabolic syndrome and with prevalent endothelial dysfunction, it was not a significant correlate across all women with the metabolic syndrome. The present data do not support the use of HR(REC) as a possible screening tool for endothelial dysfunction in obese women with the metabolic syndrome.

本研究的目的是研究伴有代谢综合征的肥胖女性心率恢复(HR(REC))与内皮功能之间的关系。代谢综合征与包括内皮功能障碍在内的心脏代谢风险增加有关。然而,通过血流介导扩张(FMD)测量内皮功能需要昂贵的设备和合格的医务人员,因此在一些医疗机构可能不切实际。心率恢复(HR(REC))对疑似冠状动脉疾病患者和代谢综合征患者发生冠状动脉疾病的风险升高的内皮功能具有预测作用。31名肥胖、久坐不动的女性(年龄:47.7±11.2岁,平均±SD)符合国际糖尿病联合会代谢综合征的标准,接受了肱动脉超声检查,以确定FMD和硝酸甘油介导的扩张(NTG)。在标准化VO(2 Peak)跑步机方案下,在5分钟主动恢复期间评估HR(REC)。结果显示,在所有参与者中,FMD百分比与HR(REC)无关(r= 0.067, p=0.72)。然而,这种关系在FMD受损的参与者中是显著的(n= 16% FMD)
{"title":"Heart rate recovery does not predict endothelial function in obese women.","authors":"Damon L Swift,&nbsp;Brian A Irving,&nbsp;David W Brock,&nbsp;Christopher K Davis,&nbsp;Eugene J Barrett,&nbsp;Glenn A Gaesser,&nbsp;Arthur Weltman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The purpose of the present study was to examine the relationship between heart rate recovery (HR(REC)) and endothelial function in obese women with the metabolic syndrome. The metabolic syndrome has been associated with increased cardiometabolic risk including endothelial dysfunction. However, measurement of endothelial function via flow-mediated dilation (FMD) requires expensive equipment and qualified medical personnel, and therefore may be impractical in some healthcare settings. Heart rate recovery (HR(REC)) has predictive utility with respect to endothelial function in individuals with suspected coronary artery disease and individuals with the metabolic syndrome also have elevated risk for developing coronary artery disease. Thirty-one obese, sedentary women (age: 47.7±11.2 yr, mean±SD) who met the International Diabetes Federation criteria for the metabolic syndrome underwent a brachial artery ultrasound to determine FMD and nitroglycerine-mediated dilation (NTG). HR(REC) was assessed during 5 min of active recovery following a standardized VO(2 Peak) treadmill protocol. Results revealed that the %FMD was not correlated to HR(REC) when examined across all participants (r= 0.067, p=0.72). However, this relationship was significant in participants with impaired FMD (n=16, %FMD<6%) (r=0.71, p=0.002). Although HR(REC) may be a significant correlate of FMD in women with the metabolic syndrome and with prevalent endothelial dysfunction, it was not a significant correlate across all women with the metabolic syndrome. The present data do not support the use of HR(REC) as a possible screening tool for endothelial dysfunction in obese women with the metabolic syndrome.</p>","PeriodicalId":37832,"journal":{"name":"Obesity and Metabolism","volume":"3 3","pages":"101-105"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338316/pdf/nihms141455.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40191911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The metabolic syndrome, hypertriglyceridemic waist, and cardiometabolic risk factor profile in obese women. 肥胖妇女的代谢综合征、高甘油三酯血症腰和心脏代谢危险因素概况
Q3 Medicine Pub Date : 2007-06-01
Brian A Irving, Christopher K Davis, David W Brock, Judy Y Weltman, Damon Swift, Eugene J Barrett, Glenn A Gaesser, Arthur Weltman

The hypertriglyceridemic waist (HTGW) and metabolic syndrome (MS) are associated with increased cardiometabolic risk. We evaluated the impact of the HTGW on cardiometabolic risk factors in obese women diagnosed with the MS. Thirty-six abdominally obese women with the MS as defined by the International Diabetes Federation (IDF) [(mean (SD); age 49 (11) y, ht 165 (6) cm, wt 95 (16) kg] participated. The HTGW was defined as follows: a waist circumference ≥80 cm and triglycerides ≥1.7 mM. Unpaired t-tests and Analysis of Covariance (ANCOVA) were employed to detect mean differences between women with MS plus or minus HTGW. Women with the MS plus HTGW had higher total cholesterol (16%, p=0.015), VLDL-cholesterol (97%, p<0.001), non-HDL-cholesterol (16%, p=0.002), insulin (40%, p=0.043), and abdominal visceral fat (24%, p=0.100), and lower total HDL-cholesterol (6%, p=0.024), HDL(3) (11%, p=0.031) and Quantitative Insulin Sensitivity Check Index (QUICKI) (5%, p=0.068) compared with women with the MS minus HTGW. Thus, the presence of the HTGW was accompanied by a worsened cardiometabolic risk factor profile in these obese women with the MS. In particular, women with the MS plus HTGW were more insulin resistant compared to women with the MS minus HTGW. In conclusion, the presence of the HTGW in obese women with the MS exacerbates insulin resistance and cardiometabolic risk factors.

高甘油三酯血症腰(HTGW)和代谢综合征(MS)与心脏代谢风险增加有关。我们评估了HTGW对诊断为多发性硬化症的肥胖女性心脏代谢危险因素的影响。36名患有国际糖尿病联合会(IDF)定义的多发性硬化症的腹部肥胖女性[(mean (SD);年龄49(11岁),身高165 (6)cm,体重95 (16)kg。HTGW的定义如下:腰围≥80 cm,甘油三酯≥1.7 mM。采用非配对t检验和协方差分析(ANCOVA)来检测MS患者加或减HTGW的平均差异。MS合并HTGW的女性总胆固醇(16%,p=0.015)和vldl -胆固醇(97%,p=0.015)较高
{"title":"The metabolic syndrome, hypertriglyceridemic waist, and cardiometabolic risk factor profile in obese women.","authors":"Brian A Irving,&nbsp;Christopher K Davis,&nbsp;David W Brock,&nbsp;Judy Y Weltman,&nbsp;Damon Swift,&nbsp;Eugene J Barrett,&nbsp;Glenn A Gaesser,&nbsp;Arthur Weltman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The hypertriglyceridemic waist (HTGW) and metabolic syndrome (MS) are associated with increased cardiometabolic risk. We evaluated the impact of the HTGW on cardiometabolic risk factors in obese women diagnosed with the MS. Thirty-six abdominally obese women with the MS as defined by the International Diabetes Federation (IDF) [(mean (SD); age 49 (11) y, ht 165 (6) cm, wt 95 (16) kg] participated. The HTGW was defined as follows: a waist circumference ≥80 cm and triglycerides ≥1.7 mM. Unpaired t-tests and Analysis of Covariance (ANCOVA) were employed to detect mean differences between women with MS plus or minus HTGW. Women with the MS plus HTGW had higher total cholesterol (16%, p=0.015), VLDL-cholesterol (97%, p<0.001), non-HDL-cholesterol (16%, p=0.002), insulin (40%, p=0.043), and abdominal visceral fat (24%, p=0.100), and lower total HDL-cholesterol (6%, p=0.024), HDL(3) (11%, p=0.031) and Quantitative Insulin Sensitivity Check Index (QUICKI) (5%, p=0.068) compared with women with the MS minus HTGW. Thus, the presence of the HTGW was accompanied by a worsened cardiometabolic risk factor profile in these obese women with the MS. In particular, women with the MS plus HTGW were more insulin resistant compared to women with the MS minus HTGW. In conclusion, the presence of the HTGW in obese women with the MS exacerbates insulin resistance and cardiometabolic risk factors.</p>","PeriodicalId":37832,"journal":{"name":"Obesity and Metabolism","volume":"3 2","pages":"50-57"},"PeriodicalIF":0.0,"publicationDate":"2007-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157146/pdf/nihms141450.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29946872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ozhirenie i polovoe razvitie: epidemiologicheskoe issledovanie detey i podrostkov Moskovskogo regiona Ozherinie i polovoe razvitie:莫斯科地区的流行病学调查
Q3 Medicine Pub Date : 2006-09-15 DOI: 10.14341/2071-8713-5258
Ivan Ivanovich Dedov, Galina A. Melnichenko, T. V. Chebotnikova, V. R. Kuchma, N. A. Skoblina, C. A. Butrova, L. V. Savel'eva, E. N. Andreeva, O. Y. Rebrova, R. M. Esayan
Работа выполнена при поддержке Совета по грантам Президента Российской Федерации для государственной поддержки молодых российских ученых (грант МК-2210.2006.7).
这项工作是在俄罗斯联邦总统拨款委员会的支持下完成的,目的是国家支持年轻俄罗斯科学家(mk -2210.2006.7)。
{"title":"Ozhirenie i polovoe razvitie: epidemiologicheskoe issledovanie detey i podrostkov Moskovskogo regiona","authors":"Ivan Ivanovich Dedov, Galina A. Melnichenko, T. V. Chebotnikova, V. R. Kuchma, N. A. Skoblina, C. A. Butrova, L. V. Savel'eva, E. N. Andreeva, O. Y. Rebrova, R. M. Esayan","doi":"10.14341/2071-8713-5258","DOIUrl":"https://doi.org/10.14341/2071-8713-5258","url":null,"abstract":"Работа выполнена при поддержке Совета по грантам Президента Российской Федерации для государственной поддержки молодых российских ученых (грант МК-2210.2006.7).","PeriodicalId":37832,"journal":{"name":"Obesity and Metabolism","volume":"3 1","pages":"14-20"},"PeriodicalIF":0.0,"publicationDate":"2006-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67044600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Problema ozhireniya: ot sindroma k zabolevaniyu 氧气问题:ot综合征
Q3 Medicine Pub Date : 2006-03-15 DOI: 10.14341/2071-8713-4936
I. I. Dedov
{"title":"Problema ozhireniya: ot sindroma k zabolevaniyu","authors":"I. I. Dedov","doi":"10.14341/2071-8713-4936","DOIUrl":"https://doi.org/10.14341/2071-8713-4936","url":null,"abstract":"","PeriodicalId":37832,"journal":{"name":"Obesity and Metabolism","volume":"3 1","pages":"2-4"},"PeriodicalIF":0.0,"publicationDate":"2006-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67044995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Dinamika faktorov riska sakharnogo diabeta 2 tipa i serdechno-sosudistykh zabolevaniy u bol'nykh s abdominal'nym tipom ozhireniya 糖尿病的风险是一种由两种类型的serdechno-saudisic障碍和腹部障碍组成的障碍。
Q3 Medicine Pub Date : 2004-06-15 DOI: 10.14341/2071-8713-4896
I. Dedov, S. A. Butrova, F. Dzgoeva
{"title":"Dinamika faktorov riska sakharnogo diabeta 2 tipa i serdechno-sosudistykh zabolevaniy u bol'nykh s abdominal'nym tipom ozhireniya","authors":"I. Dedov, S. A. Butrova, F. Dzgoeva","doi":"10.14341/2071-8713-4896","DOIUrl":"https://doi.org/10.14341/2071-8713-4896","url":null,"abstract":"","PeriodicalId":37832,"journal":{"name":"Obesity and Metabolism","volume":"1 1","pages":"19-24"},"PeriodicalIF":0.0,"publicationDate":"2004-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67044930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
13 Evropeyskiy kongress po ozhireniyu 26-29 maya, Praga 13欧洲大会,5月26日至29日,星期三,布拉格
Q3 Medicine Pub Date : 2004-06-15 DOI: 10.14341/2071-8713-4903
L. Savel'eva
{"title":"13 Evropeyskiy kongress po ozhireniyu 26-29 maya, Praga","authors":"L. Savel'eva","doi":"10.14341/2071-8713-4903","DOIUrl":"https://doi.org/10.14341/2071-8713-4903","url":null,"abstract":"","PeriodicalId":37832,"journal":{"name":"Obesity and Metabolism","volume":"1 1","pages":"48"},"PeriodicalIF":0.0,"publicationDate":"2004-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67044992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Obesity and Metabolism
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1